Project Number 1U01AG047110-01 Agency/Funding Organization NIA Funding Year 2013 View Full Project Details for SMALL MOLECULE DEVELOPMENT OF PRPC ANTAGONISTS FOR THE TREATMENT OF ALZHEIMER'S D Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) a. Amyloid beta Researcher and Organization Principal Investigator MAYNARD, GEORGE DANIEL Principal Investigator First Name GEORGE DANIEL Principal Investigator Last Name MAYNARD Awardee Organization AXERION THERAPEUTICS, INC. Awardee State Connecticut Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-NS-13-003: NIH BLUEPRINT FOR NEUROSCIENCE RESEARCH GRAND CHALLENGE: DISCOVERING NOVEL DRUGS FOR DISORDERS OF THE NERVOUS SYSTEM (U01) FY Overall Cost $200,958 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
